treating kidney cancer with axitinib &avelumab, or axitinib & pembrolizumab?
Published 3 years ago • 105 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
1:00
pembrolizumab/axitinib and avelumab/axitinib combo for rcc
-
4:25
kidney cancer updates: avelumab/axitinib, pembro/axitinib, bevacizumab/atezo & ipilimumab/nivo
-
1:06
exciting potential of pembrolizumab combined with axitinib for kidney cancer
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
2:31
axitinib plus pembrolizumab in advanced rcc
-
2:27
combining avelumab and axitinib in advanced renal cell carcinoma (rcc)
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
4:39
avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
-
1:04
dr. rini discusses pembrolizumab plus axitinib in mrcc
-
1:19
dr. rini on the efficacy of axitinib and pembrolizumab in rcc
-
1:03
dr. rini on managing the toxicity of pembrolizumab plus axitinib in mrcc
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
9:30
study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
-
2:32
avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
1:56
dr. cost on pembrolizumab plus axitinib in patients with rcc
-
1:47
dr. choueiri discusses avelumab/axitinib data in rcc
-
9:23
javelin renal 101: avelumab plus axitinib improve pfs for advanced renal cell cancer
-
1:37
immunotherapy combinations improve survival in advanced renal cell carcinoma